Streetbeat News

Products Services

MRAI

Marpai, Inc. (NASDAQ:MRAI) has announced the launch of Marpai Connect, an AI-powered platform that connects health plan participants with value-based providers. The platform aims to improve member health and lower costs for employers. MRAI plans to offer Marpai Connect to other healthcare payers starting in 4Q23.

Portfolio Pulse from Akanksha Bakshi

May 30, 2023 | 11:30 am

F

Ford Motor is expanding its Mobile Service program to include Escape SUVs, aiming to have nearly 1,000 of them as mobile service vehicles by year's end. This will provide smaller-volume dealers with a more affordable way to deliver Mobile Service and larger dealers a way to supplement their existing fleets.

Portfolio Pulse from Charles Gross

May 30, 2023 | 11:27 am

ATHE

Alterity Therapeutics has initiated a second Phase 2 study for its drug candidate ATH434 in the treatment of Multiple System Atrophy (MSA), a rare Parkinsonian disorder. The study aims to evaluate the safety, tolerability, and efficacy of the drug.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:26 am

FUV

Arcimoto has announced the availability of its new Modular Utility Vehicle (MUV), the first on-road modular utility vehicle in the company's lineup of small footprint electric vehicles for professional and commercial use. The MUV is built on Arcimoto's flagship FUV platform.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:13 am

BGNE

BeiGene announced that its drug BRUKINSA has been approved in Canada for the treatment of chronic lymphocytic leukemia. This approval could potentially boost BeiGene's (BGNE) revenues and expand its market presence.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:12 am

AAPL

INDA

Apple is resisting an order from Indian officials to remove betting apps from the App Store, potentially leading to a conflict with the Indian government.

Portfolio Pulse from Charles Gross

May 30, 2023 | 11:10 am

WBD

Warner Bros. Discovery's streaming service HBO rebranded to 'Max' and launched with a monthly subscription of $19.99 or an annual fee of $199.99. Users have reported frequent crashes, lagging video streaming, screen blackouts, and a lack of an app for Mac users. The platform's eccentric human test questions have gone viral on the internet.

Portfolio Pulse from Ananya Gairola

May 30, 2023 | 11:08 am

ACB

Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ:ACB), and Ethypharm have been selected by the French General Directorate of Health as exclusive suppliers of dried medical cannabis flower until the end of the French trial period, which has been extended until March 2024.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:07 am

MDWD

MediWound announced the expected US launch of NexoBrid in early Q3 of 2023 and plans to expand its manufacturing facility to meet increasing global demand. The expansion project is set to be completed by the end of 2024, increasing production capacity by five-fold. The company's global Phase III clinical study for EscharEx is expected to begin in Q4 of 2023.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 11:06 am